India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
At least one recognised startup in every State and UT; spread across over 80% of districts
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
Subscribe To Our Newsletter & Stay Updated
